BioVendor R D

10. 3. 2025

ARCHIMED is a global investment firm specialising in the healthcare industries, with biotechnology and diagnostics being among the core investment areas. With an international presence, ARCHIMED joins forces with scientists, healthcare professionals, entrepreneurs and investors to positively impact companies operating in these sectors. In particular, ARCHIMED focuses on supporting these companies in their efforts to internationalise, increase capacity, expand product ranges and make acquisitions. 

ARCHIMED invests in companies with strong potential, and their approach is always based on long-term and strategic value creation. They not only provide financial support but also share expertise and leverage their companies and MEDTalent® network to foster collective sustainable growth, ultimately improving patients’ outcome.

Joining forces with ARCHIMED allows us to expand our activities, strengthen our technological foundation, and offer even higher-quality services. At the same time, we remain a team grounded in the same values, expertise, and commitment. 

In a statement, Michal Kostka, CEO of BioVendor Group, said: "ARCHIMED is taking over the baton in a well-paced long-distance race, ensuring that our momentum continues and our journey towards growth and innovation remains strong."